The National Association of Chain Drug Stores recognized U.S. Sen. Kay Hagan for her continued leadership on behalf of pharmacy patient care.

The 14th annual National Association of Chain Drug Stores Foundation dinner raised nearly $1.8 million to fund research, charity and scholarships, the foundation said Wednesday.

As the U.S. Senate and House of Representatives examined the meningitis outbreak this week, the National Association of Chain Drug Stores distinguished between the types of pharmacy compounding and the settings in which they take place, and emphasized the critical, life-saving benefits of pharmacy compounding.

Americans woke up Wednesday morning to the news that Barack Obama had won a second term as president of the United States. DSN examines what it means for retail pharmacy.

The National Association of Chain Drug Stores has announced that it will participate in the annual U.S. Senate Health Fair, which will take place on Oct. 11 to 12 in the U.S. Senate Office complex on Capitol Hill in Washington, D.C.

Serving as co-chair of the 13th Annual Summit Awards Dinner — which was presented by the American Society of Association Executives - the Center for Association Leadership Wednesday evening at the National Building Museum in Washington, D.C. — National Association of Chain Drug Stores president and CEO Steve Anderson emphasized to more than 1,100 attendees that associations serve a vital function as the "fifth estate" in the 21st century American democracy.

“Drugs don’t work in patients who don’t take them.” Sounds simple enough. But that obvious truism, voiced by former U.S. surgeon general C. Everett Koop, fails to convince tens of millions of patients that they should take their prescription medicines through the full dosage regimen.

With less than six weeks until Election Day, the National Association of Chain Drug Stores grassroots advocacy program is in high gear with its NACDS RxImpact Votes program, urging pharmacy advocates to help shape pharmacy’s future through political engagement.

When National Association of Chain Drug Stores president and CEO Steve Anderson earlier this year at NACDS Annual urged pharmacy leaders to be “disruptive innovators,” and new NACDS chairman and Walgreens president and CEO Greg Wasson called on the industry to embrace a holistic view of the total store in improving patient lives, they easily could have submitted Walgreens and its Take Care Health Systems subsidiary as an ideal case study.


In a statement issued on Monday, the National Association of Chain Drug Stores applauded the U.S. Senate for its passage of the “Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012,” also known as the “Safe Doses Act” (H.R. 4223 and S. 1002).

Over the last few years of DSN’s coverage of the impending patent cliff and how it would affect the generic drug industry, IMS Health VP industry relations Doug Long predicted that the gradual commoditization of primary care drugs — long the lifeblood of generic drug makers — would lead to consolidation of the industry.